Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes

Takahiro Machida, Keiichiro Nishida, Yoshihisa Nasu, Ryuuichi Nakahara, Masatsugu Ozawa, Ryozo Harada, Masahiro Horita, Ayumu Takeshita, Daisuke Kaneda, Aki Yoshida, Toshihumi Ozaki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To investigate whether janus kinase (JAK) inhibitor exhibits a chondro-protective effect against mechanical stress-induced expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and matrix metalloproteinase (MMPs) in human chondrocytes. Materials and methods: Normal human articular chondrocytes were seeded onto stretch chambers and incubated with or without tofacitinib (1000 nM) for 12 h before mechanical stimulation or cytokine stimulation. Uni-axial cyclic tensile strain (CTS) (0.5 Hz, 10% elongation, 30 min) was applied and the gene expression levels of type II collagen α1 chain (COL2A1), aggrecan (ACAN), ADAMTS4, ADAMTS5, MMP13, and runt-related transcription factor 2 (RUNX-2) were examined by real-time polymerase chain reaction. Nuclear translocation of RUNX-2 and nuclear factor-κB (NF-κB) was examined by immunocytochemistry, and phosphorylation of mitogen-activated protein kinase (MAPK) and signaling transducer and activator of transcription (STAT) 3 was examined by western blotting. The concentration of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the supernatant was examined by enzyme-linked immunosorbent assay. Results: COL2A1 and ACAN gene expression levels were decreased by CTS, but these catabolic effects were canceled by tofacitinib. Tofacitinib significantly down-regulated CTS-induced expression of ADAMTS4, ADAMTS5, MMP13, and RUNX2, and the release of IL-6 in supernatant by chondrocytes. Tofacitinib also reduced CTS-induced nuclear translocation of RUNX-2 and NF-κB, and phosphorylation of MAPK and STAT3. Conclusion: Tofacitinib suppressed mechanical stress-induced expression of ADAMTS4, ADAMTS5, and MMP13 by human chondrocytes through inhibition of the JAK/STAT and MAPK cascades.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalInflammation Research
DOIs
Publication statusAccepted/In press - Jul 27 2017

Fingerprint

Janus Kinases
Mechanical Stress
Chondrocytes
Peptide Hydrolases
Joints
Mitogen-Activated Protein Kinases
Aggrecans
Transducers
Interleukin-6
Phosphorylation
Thrombospondins
Disintegrins
Gene Expression
Metalloproteases
Collagen Type I
Matrix Metalloproteinases
Interleukin-1
Real-Time Polymerase Chain Reaction
Transcription Factors
Tumor Necrosis Factor-alpha

Keywords

  • Chondrocyte
  • Janus kinase
  • Mechanical stress
  • Rheumatoid arthritis
  • Tofacitinib

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes. / Machida, Takahiro; Nishida, Keiichiro; Nasu, Yoshihisa; Nakahara, Ryuuichi; Ozawa, Masatsugu; Harada, Ryozo; Horita, Masahiro; Takeshita, Ayumu; Kaneda, Daisuke; Yoshida, Aki; Ozaki, Toshihumi.

In: Inflammation Research, 27.07.2017, p. 1-11.

Research output: Contribution to journalArticle

Machida, Takahiro ; Nishida, Keiichiro ; Nasu, Yoshihisa ; Nakahara, Ryuuichi ; Ozawa, Masatsugu ; Harada, Ryozo ; Horita, Masahiro ; Takeshita, Ayumu ; Kaneda, Daisuke ; Yoshida, Aki ; Ozaki, Toshihumi. / Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes. In: Inflammation Research. 2017 ; pp. 1-11.
@article{667b9679615645d7b6bff3c0e35e93ac,
title = "Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes",
abstract = "Objective: To investigate whether janus kinase (JAK) inhibitor exhibits a chondro-protective effect against mechanical stress-induced expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and matrix metalloproteinase (MMPs) in human chondrocytes. Materials and methods: Normal human articular chondrocytes were seeded onto stretch chambers and incubated with or without tofacitinib (1000 nM) for 12 h before mechanical stimulation or cytokine stimulation. Uni-axial cyclic tensile strain (CTS) (0.5 Hz, 10{\%} elongation, 30 min) was applied and the gene expression levels of type II collagen α1 chain (COL2A1), aggrecan (ACAN), ADAMTS4, ADAMTS5, MMP13, and runt-related transcription factor 2 (RUNX-2) were examined by real-time polymerase chain reaction. Nuclear translocation of RUNX-2 and nuclear factor-κB (NF-κB) was examined by immunocytochemistry, and phosphorylation of mitogen-activated protein kinase (MAPK) and signaling transducer and activator of transcription (STAT) 3 was examined by western blotting. The concentration of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the supernatant was examined by enzyme-linked immunosorbent assay. Results: COL2A1 and ACAN gene expression levels were decreased by CTS, but these catabolic effects were canceled by tofacitinib. Tofacitinib significantly down-regulated CTS-induced expression of ADAMTS4, ADAMTS5, MMP13, and RUNX2, and the release of IL-6 in supernatant by chondrocytes. Tofacitinib also reduced CTS-induced nuclear translocation of RUNX-2 and NF-κB, and phosphorylation of MAPK and STAT3. Conclusion: Tofacitinib suppressed mechanical stress-induced expression of ADAMTS4, ADAMTS5, and MMP13 by human chondrocytes through inhibition of the JAK/STAT and MAPK cascades.",
keywords = "Chondrocyte, Janus kinase, Mechanical stress, Rheumatoid arthritis, Tofacitinib",
author = "Takahiro Machida and Keiichiro Nishida and Yoshihisa Nasu and Ryuuichi Nakahara and Masatsugu Ozawa and Ryozo Harada and Masahiro Horita and Ayumu Takeshita and Daisuke Kaneda and Aki Yoshida and Toshihumi Ozaki",
year = "2017",
month = "7",
day = "27",
doi = "10.1007/s00011-017-1083-x",
language = "English",
pages = "1--11",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes

AU - Machida, Takahiro

AU - Nishida, Keiichiro

AU - Nasu, Yoshihisa

AU - Nakahara, Ryuuichi

AU - Ozawa, Masatsugu

AU - Harada, Ryozo

AU - Horita, Masahiro

AU - Takeshita, Ayumu

AU - Kaneda, Daisuke

AU - Yoshida, Aki

AU - Ozaki, Toshihumi

PY - 2017/7/27

Y1 - 2017/7/27

N2 - Objective: To investigate whether janus kinase (JAK) inhibitor exhibits a chondro-protective effect against mechanical stress-induced expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and matrix metalloproteinase (MMPs) in human chondrocytes. Materials and methods: Normal human articular chondrocytes were seeded onto stretch chambers and incubated with or without tofacitinib (1000 nM) for 12 h before mechanical stimulation or cytokine stimulation. Uni-axial cyclic tensile strain (CTS) (0.5 Hz, 10% elongation, 30 min) was applied and the gene expression levels of type II collagen α1 chain (COL2A1), aggrecan (ACAN), ADAMTS4, ADAMTS5, MMP13, and runt-related transcription factor 2 (RUNX-2) were examined by real-time polymerase chain reaction. Nuclear translocation of RUNX-2 and nuclear factor-κB (NF-κB) was examined by immunocytochemistry, and phosphorylation of mitogen-activated protein kinase (MAPK) and signaling transducer and activator of transcription (STAT) 3 was examined by western blotting. The concentration of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the supernatant was examined by enzyme-linked immunosorbent assay. Results: COL2A1 and ACAN gene expression levels were decreased by CTS, but these catabolic effects were canceled by tofacitinib. Tofacitinib significantly down-regulated CTS-induced expression of ADAMTS4, ADAMTS5, MMP13, and RUNX2, and the release of IL-6 in supernatant by chondrocytes. Tofacitinib also reduced CTS-induced nuclear translocation of RUNX-2 and NF-κB, and phosphorylation of MAPK and STAT3. Conclusion: Tofacitinib suppressed mechanical stress-induced expression of ADAMTS4, ADAMTS5, and MMP13 by human chondrocytes through inhibition of the JAK/STAT and MAPK cascades.

AB - Objective: To investigate whether janus kinase (JAK) inhibitor exhibits a chondro-protective effect against mechanical stress-induced expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and matrix metalloproteinase (MMPs) in human chondrocytes. Materials and methods: Normal human articular chondrocytes were seeded onto stretch chambers and incubated with or without tofacitinib (1000 nM) for 12 h before mechanical stimulation or cytokine stimulation. Uni-axial cyclic tensile strain (CTS) (0.5 Hz, 10% elongation, 30 min) was applied and the gene expression levels of type II collagen α1 chain (COL2A1), aggrecan (ACAN), ADAMTS4, ADAMTS5, MMP13, and runt-related transcription factor 2 (RUNX-2) were examined by real-time polymerase chain reaction. Nuclear translocation of RUNX-2 and nuclear factor-κB (NF-κB) was examined by immunocytochemistry, and phosphorylation of mitogen-activated protein kinase (MAPK) and signaling transducer and activator of transcription (STAT) 3 was examined by western blotting. The concentration of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in the supernatant was examined by enzyme-linked immunosorbent assay. Results: COL2A1 and ACAN gene expression levels were decreased by CTS, but these catabolic effects were canceled by tofacitinib. Tofacitinib significantly down-regulated CTS-induced expression of ADAMTS4, ADAMTS5, MMP13, and RUNX2, and the release of IL-6 in supernatant by chondrocytes. Tofacitinib also reduced CTS-induced nuclear translocation of RUNX-2 and NF-κB, and phosphorylation of MAPK and STAT3. Conclusion: Tofacitinib suppressed mechanical stress-induced expression of ADAMTS4, ADAMTS5, and MMP13 by human chondrocytes through inhibition of the JAK/STAT and MAPK cascades.

KW - Chondrocyte

KW - Janus kinase

KW - Mechanical stress

KW - Rheumatoid arthritis

KW - Tofacitinib

UR - http://www.scopus.com/inward/record.url?scp=85026897371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026897371&partnerID=8YFLogxK

U2 - 10.1007/s00011-017-1083-x

DO - 10.1007/s00011-017-1083-x

M3 - Article

SP - 1

EP - 11

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

ER -